Skip to main content

Oregon State Flag An official website of the State of Oregon »

Oregon.gov Homepage

Prescription Drug Affordability Board (PDAB)

  • PDAB UPL report for Legislature

    At the Nov. 20, 2024 board meeting, PDAB approved the upper payment limit report for the Oregon Legislature. Read the report. Learn more about the board's UPL study on the UPL web page.


    • 2024 Generic Drug Report

    The Prescription Drug Affordability Board's annual generic drug report is now available on the PDAB website. The board approved the report at the May 15 meeting. The report discusses authorized generics, generic and biosimilar litigation, legislation, pricing, and substitutions, generic formulary placement, drug shortages and generics in other countries. Find the report posted on the Legislative Reports web page.

    About the PDAB

    The Prescription Drug Affordability Board is established in the Department of Consumer and Business Services under ORS 646A.693 to protect residents of Oregon, state and local governments, commercial health plans, health care providers, pharmacies licensed in Oregon and others within the health care system in this state from the high costs of prescription drugs. To learn more about the board’s work, see the FAQ page.